Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Douglas E. Joseph, DO, RVT, is Director of the Vascular Medicine Outpatient Department in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is also medical director for the Vascular Medicine Vein Health Clinic and co-medical director of the multi-disciplinary lymphedema clinic. He is board-certified in vascular medicine and Internal Medicine and is a registered vascular technologist (RVT) and Registered Physician in Vascular Interpretation (RPVI).
Dr. Joseph earned a Doctorate of Osteopathy at Des Moines University College of Osteopathic Medicine. He completed an internship and internal medicine residency at St. Vincent Mercy Medical Center in Toledo, Ohio followed by a fellowship in vascular medicine at Cleveland Clinic. He was appointed to the medical staff in 2004.
Dr. Joseph has published a number of papers in medical journals on peripheral arterial disease, heparin-induced thrombocytopenia and deep vein thrombosis. He also has authored two textbook chapters and a monograph on heparin-induced thrombocytopenia.
Currently his clinical and research interests involve chronic venous insufficiency and varicose veins. He performs endovenous ablation, microphlebectomies and sclerotherapy on the main campus as well as at multiple regional facilities.
Dr. Joseph also is a frequent presenter at medical symposia hosted at Cleveland Clinic and elsewhere, speaking on prevention of venous thromboembolism following surgery, peripheral artery disease, lower extremity wounds and management of primary venous disease.
His professional memberships include the Society of Diagnostic Medical Sonography, American Venous Forum, Society for Vascular Medicine, American Medical Association and American College of Physicians, American Society of Internal Medicine and he is a Fellow of the American Osteopathic Association.
Hypercoagulable states, lymphedema, chronic venous insufficiency, varicose veins, general vascular medicine, vascular diseases, non-invasive testing for vascular disease, sclerotherapy
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/15/2013, Dr. Joseph has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.